The cardiac pacemakers market has been categorized and split into five (5)
regions accordingly that comprises of North America, Europe, Asia Pacific,
Latin America and Middle East & Africa. North America has registered the
largest growth (in terms of value) as compared to the other nations and it
holds at least 60% of the total market share owing to robust healthcare
infrastructure and increasing number of cardiovascular diseases reported on
a yearly basis.
Growing Ageing Population
The sudden incline in the growth of ageing population over the past two
decades had led to rising number of deaths due to the occurrence of
cardiovascular diseases. Ageing has the potential to cause progressive
decline in physiological processes and increases risk of developing health
related complications and CVDs that include atherosclerosis, hypertension,
myocardial infarction, and stroke.
Request
for
a
Free
Sample
Copy
of
Report
@
https://www.researchnester.com/sample-request-1576
Adoption of Sedentary Lifestyles and unhealthy food habits
With changing lifestyles and adoption of unhealthy food habits, there has
been a sudden surge in the number of individuals affected by CVDs. This has
opened a window of opportunities for organizations from all over the world
to invest in R&D for the purpose of finding a cure for CVDs.
W.H.O. has reported a whopping 17.9 million deaths that have occurred from
CVDs during the year 2016. World Health Organization has claimed that
cardiovascular diseases are the primary causes of death globally, as more
people die from CVDs annually than any other cause.